Susquehanna Fundamental Investments, LLC Champions Oncology, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$4.11 - $6.81 $21,248 - $35,207	-5,170 Reduced 25.07%	15,449 $98,000
Q1 2023 May 16, 2023	SELL	$4.0 - $4.67 $9,924 - $11,586	-2,481 Reduced 10.74%	20,619 $82,000
Q3 2022 Nov 14, 2022	SELL	$7.21 - $9.47 $27,650 - $36,317	-3,835 Reduced 14.24%	23,100 $173,000
Q1 2022 May 16, 2022	SELL	$7.26 - $8.53 $6,635 - $7,796	-914 Reduced 3.28%	26,935 $219,000
Q4 2021 Feb 14, 2022	SELL	$7.76 - $10.23 $4,136 - $5,452	-533 Reduced 1.88%	27,849 $223,000
Q2 2021 Aug 11, 2021	BUY	$8.45 - $11.72 $239,827 - $332,637	28,382 New	28,382 $292,000

5.81M

3.3K

6.1K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $53.7M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.